We are live on ! Find out more
GCM

Glenview Capital Management Portfolio holdings

AUM $3.98B
1-Year Est. Return 20.52%
This Fund
S&P 500
This Quarter Est. Return
-5.32%
1 Year Est. Return
+20.52%
3 Year Est. Return
+68.18%
5 Year Est. Return
+87.14%
10 Year Est. Return
+400.35%
AUM
$5.08B
AUM Growth
-$638M
Cap. Flow
-$357M
Cap. Flow %
-7.03%
Top 10 Hldgs %
62.65%
Holding
54
New
9
Increased
13
Reduced
20
Closed
6

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$467M
2
CNC icon
Centene
CNC
+$104M
3
GPN icon
Global Payments
GPN
+$80.4M
4
WCC
WESCO International
WCC
+$65M
5
CAR icon
Avis
CAR
+$39.1M

Sector Composition

Rank Sector Weight
1 Healthcare 51.66%
2 Technology 14.48%
3 Industrials 10.25%
4 Materials 8.76%
5 Consumer Discretionary 3.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CAR icon
26
Avis
CAR
$4.97B
$55.4M 1.09%
529,826
+348,847
+193% +$39.1M
ELV icon
27
Elevance Health
ELV
$84.7B
$53.4M 1.05%
98,578
-75,651
-43% -$40M
BKD icon
28
Brookdale Senior Living
BKD
$3B
$47.9M 0.94%
7,006,929
-7,437,744
-51% -$50.3M
DNB
29
DELISTED
Dun & Bradstreet
DNB
$33.4M 0.66%
3,609,884
BC icon
30
Brunswick
BC
$5.28B
$31M 0.61%
425,634
-54,889
-11% -$4.48M
EXAS
31
DELISTED
Exact Sciences
EXAS
$26.6M 0.52%
629,455
+401,890
+177% +$22.1M
TFX icon
32
Teleflex
TFX
$5.91B
$25.8M 0.51%
+122,482
New +$25.7M
LYV icon
33
Live Nation Entertainment
LYV
$42.7B
$21.9M 0.43%
+233,896
New +$22.1M
VVV icon
34
Valvoline
VVV
$4.21B
$20.9M 0.41%
484,009
-1,150,044
-70% -$48.3M
GTM
35
ZoomInfo Technologies
GTM
$1.19B
$20M 0.39%
+1,567,923
New +$21.9M
EVLV icon
36
Evolv Technologies
EVLV
$1.08B
$16.7M 0.33%
6,547,937
+600,000
+10% +$1.99M
OFIX icon
37
Orthofix Medical
OFIX
$420M
$14.7M 0.29%
1,105,053
+221,928
+25% +$3.04M
CRS icon
38
Carpenter Technology
CRS
$26.7B
$14.2M 0.28%
+130,000
New +$12.5M
LYFT icon
39
Lyft
LYFT
$6.64B
$11.5M 0.23%
+816,451
New +$13.3M
MTCH icon
40
Match Group
MTCH
$8.45B
$10.8M 0.21%
+354,222
New +$11.2M
BHC icon
41
Bausch Health
BHC
$2.33B
$9.11M 0.18%
+1,307,068
New +$9.89M
DMRC icon
42
Digimarc Corp
DMRC
$172M
$9.05M 0.18%
291,855
DNA icon
43
Ginkgo Bioworks
DNA
$506M
$8.86M 0.17%
662,500
+62,500
+10% +$1.86M
FISV
44
Fiserv Inc
FISV
$28B
$8.01M 0.16%
53,768
-748,924
-93% -$113M
BFLY icon
45
Butterfly Network
BFLY
$2.5B
$6.75M 0.13%
8,033,501
RPID icon
46
Rapid Micro Biosystems
RPID
$84.8M
$793K 0.02%
1,200,788
-117,500
-9% -$100K
DOMA
47
DELISTED
Doma Holdings, Inc.
DOMA
$97.1K ﹤0.01%
15,994
BFLY.WS
48
DELISTED
Butterfly Network Inc Warrants
BFLY.WS
$40.3K ﹤0.01%
1,713,333
ARRY icon
49
Array Technologies
ARRY
$824M
-2,204,685
Closed -$32.9M
AVGO icon
50
Broadcom
AVGO
$1.98T
-200,270
Closed -$26.5M

Similar funds

Glenview Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Glenview Capital Management held 54 positions worth $5.08B, down 11% from $5.72B the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Glenview Capital Management withdrew a net $357M in Q2 2024, closing 6 positions and reducing 20 holdings. Its most notable exit was Meta Platforms (Facebook), an estimated $53.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 52% of assets, up from 43% a quarter earlier, followed by Technology and Industrials.

Against the trend, Glenview Capital Management opened a new position in Centene worth $94.9M.

  • Glenview Capital Management's largest Q2 2024 buy was Centene: 1,431,312 shares worth $94.9M.
  • Glenview Capital Management added most to CVS Health in Q2 2024, an estimated $467M increase.
  • Glenview Capital Management's biggest Q2 2024 reduction was Tenet Healthcare, cutting an estimated $200M.
  • Glenview Capital Management fully exited Meta Platforms (Facebook) in Q2 2024, selling an estimated $53.1M.
  • Glenview Capital Management's ten largest holdings make up 63% of its $5.08B portfolio in Q2 2024.
  • Glenview Capital Management opened 9 new positions and closed 6 in Q2 2024.
  • Glenview Capital Management's portfolio value fell 11% quarter-over-quarter to $5.08B.

Based on Glenview Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.